Use of acetyl L-carnitine in the therapeutical treatment of peri

Details Use of acetyl L-carnitine in the therapeutical treatment of peri Use of acetyl L-carnitine in the therapeutical treatment of peri

1987-07-27

1988-06-14

Friedman, Stanley J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Radical -xh acid, or anhydride, acid halide or salt thereof...

514555, 514556, A61K 31205

Patent

active

047512423

ABSTRACT:
Oral or parenteral administration of 1,000-2,000 mg/day of acetyl L-carnitine or an equivalent amount of a pharmacologically acceptable salt thereof to patients affected by acute or chronic peripheral neuropathy dramatically improves their symptomatological pattern.

Affiliated with

Also associated with

Rating

Use of acetyl L-carnitine in the therapeutical treatment of peri does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of acetyl L-carnitine in the therapeutical treatment of peri, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of acetyl L-carnitine in the therapeutical treatment of peri will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-505367